Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longqing Tablets for prevention of urinary tract infection after lithotripsy with indwelling ureteral stent
ChiCTR2400094783Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Dec 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Longqing in urinary tract infection (UTI) (2 arms), sponsored by Tongji Hospital. Primary endpoint: Pyuria incidence. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
Longqing
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on ChiCTR2400094783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094783.